Safety of Copastin (Cloperastine), Ivy Leaf Lozenges, and Domperidone in Early Pregnancy
Domperidone is safe to use in early pregnancy based on multiple studies showing no increased risk of major malformations, while ivy leaf extract appears safe based on limited data; however, I cannot find any relevant safety data for copastin (cloperastine) in pregnancy and therefore cannot recommend its use.
Domperidone
Domperidone can be used safely during early pregnancy for nausea and vomiting. Current guidelines specifically list domperidone among first-line antiemetics with established safety profiles 1. The 2024 BJOG guideline on nausea and vomiting in pregnancy explicitly states that dopamine antagonists including domperidone have no increased risk of teratogenesis or other adverse pregnancy outcomes 1.
Supporting Evidence:
- Multiple high-quality studies confirm safety: A 2021 large retrospective cohort study of 13,964 pregnancies exposed to domperidone (75% in first trimester) found the malformation rate was comparable to unexposed pregnancies (adjusted OR = 0.89,95% CI: 0.77-1.03) 2
- A 2021 Japanese observational cohort study showed 2.9% major malformation rate in domperidone-exposed infants versus 1.7% in controls, with no statistically significant difference (adjusted OR: 1.86,95% CI: 0.73-4.70) 3
- A 2013 prospective cohort study of 120 first-trimester exposures found similar fetal outcomes and only 3 malformations in each group (OR = 0.6,95% CI: 0.1-2.8) 4
Important Caveat:
The FDA drug label provided is for veterinary use only (EQUIDONE Gel) and explicitly states "Not for use in humans" 5. However, this does not negate the human pregnancy safety data from clinical studies and guidelines, which support its use.
Ivy Leaf (Hedera helix) Lozenges
Ivy leaf extract appears safe for short-term use during pregnancy based on limited available data. A 2021 retrospective cohort study of 165 pregnant women using English ivy leaf extract syrup showed:
- No significant difference in preterm birth rates (21.0% vs. 24.0% in controls, OR = 0.86) 6
- No significant difference in health complications among full-term newborns (0.6% vs. 3.8%, OR = 0.15) 6
- Actually showed slightly higher mean birth weight in exposed group (3 kg vs. 2.8 kg) 6
Limitations:
This is the only identified study on ivy leaf safety in pregnancy, and it was retrospective with a relatively small sample size. The study specifically notes safety for "short-term" use, so prolonged exposure data are lacking.
Copastin (Cloperastine)
I cannot recommend copastin (cloperastine) during early pregnancy due to complete absence of safety data. The FDA drug labels provided 7 are for COPAXONE (glatiramer acetate), which is a multiple sclerosis medication and completely unrelated to copastin/cloperastine, a cough suppressant. No pregnancy safety data for cloperastine were found in the provided evidence.
Clinical Approach:
For cough suppression in early pregnancy, consider safer alternatives with established safety profiles:
- Ginger has demonstrated safety and effectiveness for nausea/vomiting 8, 9
- Vitamin B6 (pyridoxine) is recommended as first-line treatment 9
- Antihistamines (H1 receptor antagonists) are considered safe first-line options 1
Summary Algorithm
For early pregnancy symptom management:
Nausea/vomiting: Use domperidone as first-line dopamine antagonist option alongside antihistamines and pyridoxine 1
Cough with productive symptoms: Ivy leaf lozenges may be used short-term, though data are limited 6
Cough suppression: Avoid copastin/cloperastine due to lack of safety data; use alternative therapies with established pregnancy safety profiles
Always consider non-pharmacologic approaches first before any medication use in early pregnancy